LifeStance CPO reports RSU and PSU vesting
LifeStance Health Group Chief People Officer Ann Varanakis reported compensation-related share activity in connection with vested restricted stock units (RSUs) and performance-based RSUs (PSUs) on March 9, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
LifeStance Health Group Chief People Officer Ann Varanakis reported compensation-related share activity in connection with vested restricted stock units (RSUs) and performance-based RSUs (PSUs) on March 9, 2026.
She acquired 26,836 and 59,789 shares of common stock at $0.00 per share through RSU and PSU settlements. To cover tax withholding obligations on these vestings, the issuer withheld a total of 44,963 shares at a reference price of $6.91 per share. The footnotes state these withholdings reduce shares delivered and do not involve any open-market sales. Following these transactions, Varanakis directly holds 422,037 shares of LifeStance common stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 8,707 | $6.91 | $60K |
| Grant/Award | Common Stock | 26,836 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 11,232 | $6.91 | $78K |
| Grant/Award | Common Stock | 59,789 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 25,024 | $6.91 | $173K |
Footnotes (5)
- F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of restricted stock units ("RSUs") that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
- F2. Represents performance-based restricted stock units ("PSUs") previously granted to the Reporting Person on March 6, 2025, which vested on March 9, 2026.
- F3. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
- F4. Represents PSUs previously granted to the Reporting Person on February 27, 2025, which vested on March 9, 2026.
- F5. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations in connection with the net settlement of PSUs that vested on March 9, 2026. The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested PSUs and do not constitute any open-market sale.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did LFST Chief People Officer Ann Varanakis report?
What do the F-coded transactions mean in the LFST Form 4 for Ann Varanakis?
AI-generated analysis. How Rhea-AI works. Not financial advice.